Molecular epidemiology of drug-resistant malaria in western Kenya highlands
Open Access
- 31 July 2008
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 8 (1) , 1-7
Abstract
Since the late 1980s a series of malaria epidemics has occurred in western Kenya highlands. Among the possible factors that may contribute to the highland malaria epidemics, parasite resistance to antimalarials has not been well investigated. Using parasites from highland and lowland areas of western Kenya, we examined key mutations associated with Plasmodium falciparum resistance to sulfadoxine – pyrimethamine and chloroquine, including dihydrofolate reductase (pfdhfr) and dihydropteroate synthetase (pfdhps), chloroquine resistance transporter gene (pfcrt), and multi-drug resistance gene 1 (pfmdr1). We found that >70% of samples harbored 76T pfcrt mutations and over 80% of samples harbored quintuple mutations (51I/59R/108N pfdhfr and 437G/540E pfdhps) in both highland and lowland samples. Further, we did not detect significant difference in the frequencies of these mutations between symptomatic and asymptomatic malaria volunteers, and between highland and lowland samples. These findings suggest that drug resistance of malaria parasites in the highlands could be contributed by the mutations and their high frequencies as found in the lowland. The results are discussed in terms of the role of drug resistance as a driving force for malaria outbreaks in the highlands.Keywords
This publication has 48 references indexed in Scilit:
- Reconciling national treatment policies and drug regulation in KenyaHealth Policy and Planning, 2007
- Return of Chloroquine Antimalarial Efficacy in MalawiNew England Journal of Medicine, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Drug Susceptibility and Genetic Evaluation of Plasmodium falciparum Isolates Obtained in Four Distinct Geographical Regions of KenyaAntimicrobial Agents and Chemotherapy, 2004
- Reemergence of Chloroquine‐SensitivePlasmodium falciparumMalaria after Cessation of Chloroquine Use in MalawiThe Journal of Infectious Diseases, 2003
- A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in TanzaniaInfection, Genetics and Evolution, 2002
- Chloroquine‐Resistant MalariaThe Journal of Infectious Diseases, 2001
- Using evidence to change antimalarial drug policy in KenyaTropical Medicine & International Health, 2000
- Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- PCR and strain identification in Plasmodium falciparumParasitology Today, 1993